naltrexone and clocinnamox

naltrexone has been researched along with clocinnamox in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (17.65)18.2507
2000's9 (52.94)29.6817
2010's4 (23.53)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Broadbear, J; Carrington, S; Husbands, SM; Lewis, JW; Moynihan, HA; Nieland, NP; Traynor, JR; Woods, JH1
Husbands, SM; Lewis, JW; Moynihan, H; Rennison, D; Traynor, JR1
Broadbear, JH; Greedy, BM; Husbands, SM; Jales, AR; Lewis, JW; Moynihan, H; Purington, L; Rennison, D; Traynor, JR; Woods, JH1
Burke, TF; Comer, SD; Lewis, JW; Woods, JH1
Burke, TF; Lewis, JW; Medzihradsky, F; Woods, JH1
Butelman, ER; Ko, MC; Traynor, JR; Woods, JH1
Broadbear, JH; Burke, TF; Husbands, SM; Lewis, JW; Sumpter, TL; Traynor, JR; Woods, JH1
Barrett, AC; Picker, MJ; Smith, ES1
Ko, MC; Rice, KC; Williams, KL; Woods, JH1
Canpolat, S; Kelestimur, H; Kumru, S; Kutlu, S; Ozcan, M; Sandal, S; Yilmaz, B1
Arita, H; Chiba, S; Hanaoka, K; Hayashida, M; Sekiyama, H; Shu, H1
Chiba, S; Hayashida, M; Nishiyama, T; Shu, H; Yamada, Y; Yoshikawa, M1
Duarte, ID; Pacheco, Dda F; Romero, TR1
Castor, MGME; Diniz, DA; Duarte, IDG; Navarro, LC; Petrocchi, JA; Romero, TRL; Souza, TC1
Castor, MGME; Duarte, IDG; Guzzo, LS; Klein, A; Petrocchi, JA; Romero, TRL; Soares Santos, RR1
Caliari, MV; de Almeida, DL; Duarte, IDG; Lima Romero, TR; Paiva-Lima, P; Petrocchi, JA; Queiroz-Junior, C1
Cruz, JS; de Macedo, FHP; Duarte, IDG; Ferreira, RCM; Gonçalves, WA; Gualdron, M; Machado, FS; Mahecha, GAB; Perez, AC; Rezende, BM; Romero, TRL1

Other Studies

17 other study(ies) available for naltrexone and clocinnamox

ArticleYear
Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones.
    Journal of medicinal chemistry, 2006, Aug-24, Volume: 49, Issue:17

    Topics: Cinnamates; Codeine; Drug Design; Ligands; Molecular Structure; Morphine Derivatives; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship

2006
Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effects of changes to the chain linking of the C14-amino group to the aryl ring.
    Journal of medicinal chemistry, 2006, Oct-05, Volume: 49, Issue:20

    Topics: Amines; Analgesics; Animals; Cell Line; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Mice; Morphine Derivatives; Narcotic Antagonists; Pain Measurement; Radioligand Assay; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship

2006
14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity.
    Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6

    Topics: Hydrocodone; Magnetic Resonance Spectroscopy; Naltrexone; Receptors, Opioid, mu; Spectrometry, Mass, Electrospray Ionization

2009
Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:3

    Topics: Analgesia; Animals; Cinnamates; Dose-Response Relationship, Drug; Fentanyl; Male; Mice; Morphine; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Receptors, Opioid

1992
Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:2

    Topics: Analgesia; Animals; Benzimidazoles; Cinnamates; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Mice; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu

1994
Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:2

    Topics: Analgesics, Opioid; Animals; Cinnamates; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Female; Macaca mulatta; Male; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa

1998
Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:3

    Topics: Analgesics, Opioid; Animals; Binding, Competitive; Cerebral Cortex; Cinnamates; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Mice; Morphine; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Pain Measurement; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

2000
Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:3

    Topics: Animals; Cinnamates; Columbidae; Female; Fentanyl; Methadone; Morphine; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Narcotics; Reaction Time; Receptors, Opioid, mu; Sufentanil

2003
Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
    Psychoneuroendocrinology, 2003, Volume: 28, Issue:4

    Topics: Adrenocorticotropic Hormone; Animals; Cinnamates; Dose-Response Relationship, Drug; Female; Hydrocortisone; Hypothalamo-Hypophyseal System; Macaca mulatta; Male; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Pituitary-Adrenal System

2003
Mu opioid modulation of oxytocin secretion in late pregnant and parturient rats. Involvement of noradrenergic neurotransmission.
    Neuroendocrinology, 2004, Volume: 79, Issue:4

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Cinnamates; Enzyme-Linked Immunosorbent Assay; Estrogens; Female; Methoxyhydroxyphenylglycol; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Narcotics; Norepinephrine; Oxytocin; Paraventricular Hypothalamic Nucleus; Pregnancy; Progesterone; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Supraoptic Nucleus

2004
Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappa-opioid receptors.
    Journal of ethnopharmacology, 2006, Jun-30, Volume: 106, Issue:2

    Topics: Aconitum; Analgesics, Opioid; Animals; Cinnamates; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Drugs, Chinese Herbal; Male; Mice; Morphine; Morphine Derivatives; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Pain Threshold; Plant Tubers; Receptors, Opioid, kappa; Time Factors

2006
Inhibitory effect of low-dose pentazocine on the development of antinociceptive tolerance to morphine.
    Journal of anesthesia, 2009, Volume: 23, Issue:1

    Topics: Analgesics, Opioid; Animals; Cinnamates; Dose-Response Relationship, Drug; Drug Tolerance; Male; Mice; Mice, Inbred ICR; Morphine; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Pain Measurement; Pentazocine; Pressure; Receptors, Opioid, kappa

2009
Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors.
    Brain research, 2014, May-08, Volume: 1562

    Topics: Aminopeptidases; Analgesics; Animals; Brain; Cinnamates; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hot Temperature; Ketamine; Leucine; Male; Mice; Morphine Derivatives; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptive Pain; Opioid Peptides; Pain Perception; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

2014
Serotonin induces peripheral antinociception via the opioidergic system.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 97

    Topics: Analgesics; Animals; Cinnamates; Dinoprostone; Disease Models, Animal; Male; Mice; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain; Receptors, Opioid; Serotonin

2018
Noradrenaline induces peripheral antinociception by endogenous opioid release.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:4

    Topics: Analgesics; Animals; Cinnamates; Dinoprostone; Dose-Response Relationship, Drug; Hyperalgesia; Leucine; Male; Morphine Derivatives; Naltrexone; Norepinephrine; Opioid Peptides; Pain Measurement; Prazosin; Propranolol; Rats; Yohimbine

2018
Peripheral antinociception induced by ketamine is mediated by the endogenous opioid system.
    European journal of pharmacology, 2019, Dec-15, Volume: 865

    Topics: Analgesics; Animals; Cinnamates; Dinoprostone; Ketamine; Male; Mice; Morphine Derivatives; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Receptors, Opioid, delta; Receptors, Opioid, mu

2019
Endogenous opioid and cannabinoid systems modulate the muscle pain: A pharmacological study into the peripheral site.
    European journal of pharmacology, 2021, Jun-15, Volume: 901

    Topics: Animals; Arachidonic Acids; Carrageenan; Cinnamates; Endocannabinoids; Hyperalgesia; Male; Monoacylglycerol Lipases; Morphine Derivatives; Myalgia; Naloxone; Naltrexone; Pain Measurement; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

2021